{
    "Symbol": "GPTHEALTH",
    "ISIN": "INE486R01017",
    "News": [
        {
            "Title": "GPT Healthcare schedules Q3 FY26 earnings call",
            "Summary": "GPT Healthcare Limited announces earnings call on February 3, 2026 at 10:00 AM IST to discuss Q3 & 9MFY26 financial results ended December 31, 2025.",
            "Sentiment": "neutral",
            "PublishDate": 1769528417220,
            "Source": "co_actions_results"
        },
        {
            "Title": "GPT Healthcare Appoints MUFG Intime for IR Services",
            "Summary": "GPT Healthcare Limited has appointed MUFG Intime India Private Ltd as its investor relations agency effective January 1, 2026, to strengthen investor communication and enhance capital market visibility.",
            "Sentiment": "positive",
            "PublishDate": 1766733410890,
            "Source": "stocks"
        },
        {
            "Title": "GPT Healthcare Reports 12.5% Revenue Growth to INR 118.9 Crores in Q2 FY26, EBITDA Margin at 20%",
            "Summary": "GPT Healthcare achieved revenue growth of 12.5% year-on-year to INR 118.9 crores with profit after tax of INR 10.6 crores, though EBITDA dropped 10% due to initial losses from new Raipur hospital operations. The company signed an MOU for a 150-bed hospital in Jamshedpur with INR 70 crores investment and targets becoming a 1,000-bed hospital chain over the next two years.",
            "Sentiment": "positive",
            "PublishDate": 1763090294989,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Reports 9.8% Revenue Growth to Rs 228.92 Cr in H1FY26",
            "Summary": "GPT Healthcare Limited reported total income of Rs 228.92 crore for H1FY26, representing a 9.8% increase from Rs 208.5 crore in H1FY25. Revenue from operations grew 11% to Rs 226 crore. However, net profit declined 26.2% to Rs 18.3 crore from Rs 24.7 crore in the previous year. EBITDA margin compressed to 18.8% from 22.2% in H1FY25. The company operates 719 beds across five multispecialty hospitals in Eastern India with an overall bed occupancy rate of 44.7%. Average revenue per occupied bed stood at Rs 38,376. The company recently commissioned a new 158-bed hospital in Raipur in May 2025 and declared an interim dividend of Re 1 per share. GPT Healthcare targets becoming a 1,000-bed facility within the next two years, focusing on Tier I and Tier II cities in Eastern India.",
            "Sentiment": "neutral",
            "PublishDate": 1762606020377,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Reports Mixed Q2 Results, Declares Interim Dividend",
            "Summary": "GPT Healthcare's board recommended an interim dividend of 1 rupee per share. The company reported Q2 net profit of 106 million rupees, down from 148 million rupees in the same period last year. Revenue increased to 1.19 billion rupees from 1.05 billion rupees year-over-year. EBITDA declined to 227.4 million rupees from 234.2 million rupees, with EBITDA margin falling to 19.13% from 22.17% in the previous year.",
            "Sentiment": "neutral",
            "PublishDate": 1762598773711,
            "Source": "corporate_action"
        },
        {
            "Title": "GPT Healthcare Appoints Shree Gopal Tantia as Director Following Executive Chairman's Demise",
            "Summary": "GPT Healthcare Ltd announced the appointment of Mr. Shree Gopal Tantia as an Additional Non-Executive Non-Independent Director following the demise of Executive Chairman Shri Dwarika Prasad Tantia. The company's board approved several key decisions including alterations to its Articles of Association and reconstitution of the Corporate Social Responsibility Committee. The new CSR Committee will be chaired by Dr. Om Tantia, with Dr. Aruna Tantia and Dr. Tapti Sen as members. Mr. Shree Gopal Tantia, aged 60+ years, is a promoter with over 40 years of experience in infrastructure and civil construction. The company has also approved a postal ballot notice seeking shareholder approval for Tantia's appointment and the Articles of Association changes. The board meeting was held on September 24, 2025.",
            "Sentiment": "neutral",
            "PublishDate": 1758713312591,
            "Source": "corporate_governance"
        },
        {
            "Title": "GPT Healthcare Executive Chairman and Promoter Dwarika Prasad Tantia Passes Away",
            "Summary": "GPT Healthcare Limited announced the death of Shri Dwarika Prasad Tantia, Executive Chairman and Promoter, on August 17, 2025. Tantia held 300 shares in the company and served as Chairman of both GPT Healthcare and the GPT Group. He also held the position of Honorary Consul of the Republic of Ghana in Kolkata. The company described his death as sudden and unexpected, calling it an irreparable loss. GPT Healthcare stated that operations and prospects remain unchanged and committed to upholding his legacy while continuing the mission and values he established.",
            "Sentiment": "negative",
            "PublishDate": 1755539202936,
            "Source": "corporate_governance"
        },
        {
            "Title": "GPT Healthcare Reports 9.5% Revenue Growth to INR107 Crores in Q1 FY26, Opens New 158-Bed Raipur Hospital",
            "Summary": "GPT Healthcare Limited reported revenue from operations of INR107 crores for the first quarter, representing 9.5% growth. EBITDA stood at INR18.9 crores with a 17.9% margin, impacted by initial losses of approximately INR4.5 crores from the new Raipur hospital. Excluding these losses, EBITDA margin would be around 22%. Profit after tax was INR7.7 crores with a 7.7% margin. The company commissioned a 158-bed facility in Raipur on May 2, 2025, under an asset-light model, bringing total bed capacity to 719 beds across five hospitals. The Raipur hospital achieved 7% occupancy in 1.5 months with ARPOB of INR39,180. Network-wide bed occupancy stands at 42% due to the new hospital addition. ALOS improved to 3.4 days from 3.54 days, and ARPOB was INR38,913. The company signed an MoU for a 150-bed hospital in Jamshedpur with INR60 crores investment, expected to be commissioned by end of calendar year 2026. Management expects EBITDA breakeven for Raipur hospital in 12-15 months and targets reaching 1,000 beds within 2 years.",
            "Sentiment": "positive",
            "PublishDate": 1754730428562,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Shares Fall 11% Below IPO Price After Quarterly Results Show Profit Decline",
            "Summary": "GPT Healthcare shares dropped over 10% following its June quarter results. The Kolkata-based healthcare services provider reported revenue growth of 9.5% year-over-year to \u20b9107.1 crore, but net profit declined 23% to \u20b97.7 crore. EBITDA margin compressed to 16.2% from 18.4% in the previous year. The stock fell 11% to \u20b9159.11, trading below its IPO price of \u20b9186 for the third consecutive day. The company plans to expand to a 1,000-bed chain within 2-3 years, having commissioned a 158-bed hospital in Raipur and signed an MoU for a 150-bed facility in Jamshedpur costing \u20b974 crore, expected to be operational by end of financial year 2027.",
            "Sentiment": "negative",
            "PublishDate": 1754544178989,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Targets 1,000-Bed Capacity in Two Years Through East India Expansion",
            "Summary": "GPT Healthcare has announced plans to reach 1,000-bed capacity within two years through expansion in East India and development of new asset-light hospitals. The company's growth strategy includes implementing robotic surgery capabilities and enhancing oncology services. GPT Healthcare aims to achieve occupancy rates above 70% to drive Return on Equity (ROE) and Return on Capital Employed (ROCE) above 25%.",
            "Sentiment": "positive",
            "PublishDate": 1754482940716,
            "Source": "stock"
        },
        {
            "Title": "GPT Healthcare Reports Q1 Results with Revenue Growth and Profit Decline",
            "Summary": "GPT Healthcare Limited released its unaudited financial results for the quarter ended June 30, 2025. The company reported revenue from operations of \u20b910,710.86 lakhs, up from \u20b99,781.98 lakhs in the same quarter last year. Total income increased to \u20b910,867.16 lakhs from \u20b910,005.59 lakhs year-over-year. However, profit after tax declined to \u20b9768.18 lakhs compared to \u20b9996.45 lakhs in the corresponding quarter of the previous year. Total expenses rose to \u20b99,755.80 lakhs from \u20b98,538.70 lakhs. Basic and diluted earnings per share stood at \u20b90.94 versus \u20b91.21 in the same quarter last year. The results were approved by the Board of Directors and reviewed by the Audit Committee. The company operates in a single business segment of healthcare services in India and has no subsidiaries, associates, or joint ventures.",
            "Sentiment": "neutral",
            "PublishDate": 1754478880519,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Schedules Q1 FY26 Earnings Call for August 7, 2025",
            "Summary": "GPT Healthcare Limited has scheduled an earnings call on August 7, 2025 at 11:00 AM IST to discuss the unaudited financial results for the first quarter ended June 30, 2025. The call will be represented by Mr. Atul Tantia (Group CFO), Mr. Anurag Tantia (Executive Director), and Mrs. Kriti Tantia (CFO). The company has provided dial-in details including primary numbers for domestic participants and international toll-free numbers for Hong Kong, Singapore, UK, and USA. The earnings call announcement was made through a communication to stock exchanges NSE and BSE, signed by Company Secretary Ankur Sharma.",
            "Sentiment": "neutral",
            "PublishDate": 1753707999500,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Reports Q4 Financial Results",
            "Summary": "GPT Healthcare has released its Q4 financial results. The company reported an EBITDA of 206.9 million rupees, down from 232 million rupees year-over-year. The EBITDA margin decreased to 20.4% from 23.3% in the same period last year. Revenue for Q4 increased to 1 billion rupees from 994 million rupees year-over-year. The standalone net profit for Q4 was 129 million rupees, slightly up from 128 million rupees year-over-year and 122.5 million rupees quarter-over-quarter.",
            "Sentiment": "neutral",
            "PublishDate": 1748015579000,
            "Source": "result"
        },
        {
            "Title": "GPT Healthcare Reports Q3 Revenue Growth",
            "Summary": "GPT Healthcare announced its third quarter revenue of 1 billion rupees, showing an increase from 966 million rupees in the same quarter of the previous year.",
            "Sentiment": "positive",
            "PublishDate": 1739258127000,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Reports Q3 EBITDA and Margin Results",
            "Summary": "GPT Healthcare has announced its Q3 financial results. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter was 213 million rupees, compared to 210 million rupees in the same quarter of the previous year. This represents a slight year-over-year increase. However, the EBITDA margin decreased from 21.74% to 20.80% year-over-year, indicating a slight decline in profitability relative to revenue.",
            "Sentiment": "neutral",
            "PublishDate": 1739258092000,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Reports Increase in Q3 Net Profit",
            "Summary": "GPT Healthcare has announced its financial results for the third quarter, reporting a net profit of 122 million rupees. This represents an increase from the 115 million rupees reported in the same period last year, indicating a year-over-year growth in profitability.",
            "Sentiment": "positive",
            "PublishDate": 1739258052000,
            "Source": "earnings"
        },
        {
            "Title": "GPT Healthcare Signs MOU for New Hospital in Jamshedpur",
            "Summary": "GPT Healthcare has entered into a Memorandum of Understanding (MOU) for the construction of a new hospital in Jamshedpur. This agreement marks a significant step in the company's expansion plans and commitment to improving healthcare infrastructure in the region.",
            "Sentiment": "positive",
            "PublishDate": 1733417806000,
            "Source": "corporate_action"
        },
        {
            "Title": "GPT Healthcare Reports Q2 Revenue Growth",
            "Summary": "GPT Healthcare has reported a revenue of 1.1 billion rupees for the second quarter, compared to 1.08 billion rupees in the same period last year, indicating a year-over-year increase.",
            "Sentiment": "positive",
            "PublishDate": 1731577474000,
            "Source": "result"
        },
        {
            "Title": "GPT Healthcare Reports Q2 EBITDA Decline",
            "Summary": "GPT Healthcare's Q2 EBITDA decreased to 232 million rupees from 246 million rupees year-over-year. The company's EBITDA margin also declined slightly to 22.17% from 22.78% in the same period last year.",
            "Sentiment": "negative",
            "PublishDate": 1731577458000,
            "Source": "result"
        },
        {
            "Title": "GPT Healthcare Reports Increase in Q2 Net Profit",
            "Summary": "GPT Healthcare has announced its financial results for the second quarter, reporting a net profit of 148 million rupees. This represents an increase from the 135 million rupees reported in the same quarter of the previous year.",
            "Sentiment": "positive",
            "PublishDate": 1731577442000,
            "Source": "result"
        }
    ]
}